Cargando…
RGC Neuroprotection Following Optic Nerve Trauma Mediated By Intranasal Delivery of Amnion Cell Secretome
PURPOSE: Intranasally delivered ST266, the biological, proteinaceous secretome of amnion-derived multipotent progenitor cells, reduces retinal ganglion cell (RGC) loss, optic nerve inflammation, and demyelination in experimental optic neuritis. This unique therapy and novel administration route deli...
Autores principales: | Grinblat, Gabriela A., Khan, Reas S., Dine, Kimberly, Wessel, Howard, Brown, Larry, Shindler, Kenneth S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959511/ https://www.ncbi.nlm.nih.gov/pubmed/29847652 http://dx.doi.org/10.1167/iovs.18-24096 |
Ejemplares similares
-
SIRT1 and NRF2 Gene Transfer Mediate Distinct Neuroprotective Effects Upon Retinal Ganglion Cell Survival and Function in Experimental Optic Neuritis
por: McDougald, Devin S., et al.
Publicado: (2018) -
Increased ER Stress After Experimental Ischemic Optic Neuropathy and Improved RGC and Oligodendrocyte Survival After Treatment With Chemical Chaperon
por: Kumar, Varun, et al.
Publicado: (2019) -
Velocity Discrimination in Infantile Nystagmus Syndrome
por: Dai, Bing, et al.
Publicado: (2021) -
Perception of Coherent Motion in Infantile Nystagmus Syndrome
por: Dai, Bing, et al.
Publicado: (2022) -
Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)
por: Wall, Michael, et al.
Publicado: (2016)